ICD9 codes cannot reliably identify hemorrhagic transformation of ischemic stroke

Circulation: Cardiovascular Quality and Outcomes

Volumn 6, Issue 4, 2013, Pages 505-506

  Mullen, Michael T ^a   Moomaw, Charles J ^b   Alwell, Kathleen ^b   Khoury, Jane C ^b   Kissela, Brett M ^b   Woo, Daniel ^b   Flaherty, Matthew L ^b   Khatri, Pooja ^b   Adeoye, Opeolu ^b   Ferioli, Simona ^b   Kleindorfer, Dawn ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Hemorrhagic transformation; ICD9; Ischemic stroke

Indexed keywords

ALTEPLASE;

ACCURACY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL CLASSIFICATION; CODING ALGORITHM; HEALTH CARE QUALITY; HEMORRHAGIC TRANSFORMATION; HOSPITAL DISCHARGE; HUMAN; ICD-9; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; NOTE; PRIORITY JOURNAL; RELIABILITY; SUBARACHNOID HEMORRHAGE;

HEMORRHAGIC TRANSFORMATION; ICD9; ISCHEMIC STROKE;

BRAIN ISCHEMIA; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; INTRACRANIAL HEMORRHAGES; KENTUCKY; OHIO; PROGNOSIS; QUALITY INDICATORS, HEALTH CARE; STROKE; TERMINOLOGY AS TOPIC;

EID: 84884480742     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.113.000215     Document Type: Note

References (7)

1. Tanne D. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the multicenter rt-pa acute stroke survey. Circulation. 2002;105:1679-1685.
2. Bateman BT, Schumacher HC, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, Pile-Spellman J. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002. Stroke. 2006;37:440-446.
3. Dubinsky R, Lai SM. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample. Neurology. 2006;66:1742-1744.
4. Qureshi AI, Chaudhry SA, Rodriguez GJ, Suri MF, Lakshminarayan K, Ezzeddine MA. Outcome of the 'drip-and-ship' paradigm among patients with acute ischemic stroke: results of a statewide study. Cerebrovasc Dis Extra. 2012;2:1-8.
5. Kleindorfer DO, Khoury J, Moomaw CJ, Alwell K, Woo D, Flaherty ML, Khatri P, Adeoye O, Ferioli S, Broderick JP, Kissela BM. Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke. 2010;41:1326-1331.
6. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke-the Cleveland area experience. JAMA. 2000;283:1151-1158.
7. Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM; Cleveland Clinic Health System Stroke Quality Improvement Team. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol. 2004;61:346-350.